Robert Andrade - Sep 21, 2022 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade, Chief Financial Officer
Stock symbol
FENC
Transactions as of
Sep 21, 2022
Transactions value $
-$162,704
Form type
4
Date filed
9/22/2022, 11:02 AM
Previous filing
Dec 20, 2021
Next filing
Dec 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Award $0 +37.5K +24.47% $0.00 191K Sep 21, 2022 Direct F1
transaction FENC Common shares Disposed to Issuer -$163K -19.1K -9.99% $8.54 172K Sep 21, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 21, 2022, 37,500 restricted share units were released from their restriction.
F2 On September 21, 2022, 19,052 shares were netted back to the company to pay the taxes on the common shares released from restriction.